secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2024-06-03T23:59:59+00:00
Accession:  0001193125-24-152343
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics receives Nasdaq delisting notice; trading to suspend June 4
-------------------------------------------------------------------------------

- Notice from Nasdaq on May 31, 2024 for failure to meet minimum market value, bid price, and publicly held shares requirements.
- Nasdaq will suspend trading of common stock (GRTX) at open on June 4, 2024.
- Company expects common stock to be quoted on OTC Markets under symbol GRTX.
- Company has the right to request a review of the Nasdaq Hearings Panel's decision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524152343/0001193125-24-152343-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524152343/d758518d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-152343

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer